tirzepatide body composition surmount-1 trial non-diabetic obesity weight loss vs semaglutide: A new battle in treatment changes during weight – Losing weight without preserving muscle

We encourage open communication about any side effects you experience, as we can offer strategies to help manage them or adjust your plan if necessary

Redness, swelling, or pain at the injection site can happen occasionally, like with any other injection

Patients often report a shift in how their body responds to food and exercise

Cagrilintide is the long-acting amylin analog that Novo Nordisk pairs with semaglutide in CagriSema the combination that produced up to 22.7% weight loss in the REDEFINE-1 Phase 3 trial

If weight management is the main issue, you can browse the Weight Management Posts collection for related education

If a missed dose occurs, its important to follow medical guidance to prevent unintended effects